Results 211 to 220 of about 684,537 (259)

Interleukin-4 protects retinal ganglion cells and promotes axon regeneration. [PDF]

Cell Commun Signal
Zuo Z, Fan B, Zhang Z, Liang Y, Chi J, Li G.   +5 more
europepmc   +1 more source

Expanding the potential of monoclonal antibodies against interleukin-4 and interleukin-13 in genodermatoses: A case series on the efficacy and safety of dupilumab in epidermolysis bullosa and ichthyosis. [PDF]

JAAD Case Rep
Caroppo F, Mazzetto R, Milan E, Cassalia F, Belloni Fortina A.   +4 more
europepmc   +1 more source

Association between 25-hydroxy vitamin D, interleukin-4, and interferon-γ levels and asthma in children with Mycoplasma pneumonia infection. [PDF]

Sci Rep
Shen T, Liu T, Kong L, Li Y.
europepmc   +1 more source

Mineral coated microparticles delivering Interleukin-4, Interleukin-10, and Interleukin-13 reduce inflammation and improve function after spinal cord injury in a rat. [PDF]

Exp Neurol
Hellenbrand DJ, Lee JS, Mickelson EJ, Baer MC, Ott EL, Martinson NR, Ceelen MR, Hilger KH, Nielsen BE, Jacobs AN, Mishra RR, Hurley SA, Murphy WL, Hanna AS.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Interleukin 4

International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1990
Since its discovery in 1982, numerous biological activities of interleukin-4 (IL-4) have been described. Like other cytokines, IL-4 is highly pleiotropic, both with respect to the number of different target cells that are responsive to it and with respect to the number of different biological responses it elicits.
J H, Jansen, W E, Fibbe, R, Willemze, J C, Kluin-Nelemans   +3 more
  +6 more sources

Interleukin‐4 and listeriosis

Immunological Reviews, 1997
Summary: Experimental infection of mice with Listeria monocytogenes (L. monocytogenes) has served as an appropriate model for analyzing Thl nil driven immune responses. Generally, Th2 responses are absent and IL‐4 is not detectable. Here, we describe experimental settings under which IL‐4 is detectable in listeriosis.
Kaufmann, S., Emoto, M., Szalay, G., Barsig, J., Flesch, I.   +4 more
openaire   +3 more sources

Interleukin‐4 and the interleukin‐4 receptor in allergic contact dermatitis

Contact Dermatitis, 1998
Cutaneous immune responses involving T helper (TH) type 1 (TH1) and type 2 (TH2) T cells, characterised by secretion of interferon‐γ (Ifn‐γ) and interleukin‐4 (IL‐4), respectively, have both been reported in allergic contact dermatitis (ACD). We used immunohistochemistry to localize expression of IL‐4 in ACD lesions and unaffected skin.
A, Rowe, C B, Bunker
openaire   +2 more sources

Interleukin-4 as a therapeutic target

Pharmacology & Therapeutics, 2023
Interleukin-4 (IL-4) is a pleiotropic cytokine mainly known for its role in type 2 immunity. Therapies antagonizing or blocking IL-4 activity have been developed to counteract diseases such as atopic dermatitis and asthma. In contrast, other disorders experimentally benefit from IL-4-related effects and IL-4 recently demonstrated beneficial activity in
Yvonne, Gärtner, Lynn, Bitar, Frauke, Zipp, Christina Francisca, Vogelaar   +3 more
openaire   +2 more sources

Role of interleukin-4 in atherosclerosis

Archives of Pharmacal Research, 2006
Vascular endothelial cell injury or dysfunction has been implicated in the onset and progression of cardiovascular diseases including atherosclerosis. A number of previous studies have demonstrated that the pro-oxidative and pro-inflammatory pathways within vascular endothelium play an important role in the initiation and progression of atherosclerosis.
Yong Woo, Lee, Anjali A, Hirani
openaire   +2 more sources